Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'High, KA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 73 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Arruda, VR; Fields, PA; Milner, R; Wainwright, L; De Miguel, MP; Donovan, PJ; Herzog, RW; Nichols, TC; Biegel, JA; Razavi, M; Dake, M; Huff, D; Flake, AW; Couto, L; Kay, MA; High, KA
      Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males

      MOLECULAR THERAPY
    2. Herzog, RW; Mount, JD; Arruda, VR; High, KA; Lothrop, CD
      Muscle-directed gene transfer and transient immune suppression result in sustained partial correction of canine hemophilia B caused by a null mutation

      MOLECULAR THERAPY
    3. Fields, PA; Arruda, VR; Armstrong, E; Chu, K; Mingozzi, F; Hagstrom, JN; Herzog, RW; High, KA
      Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9

      MOLECULAR THERAPY
    4. High, KA
      Gene therapy: a 2001 perspective

      HAEMOPHILIA
    5. Fields, PA; Armstrong, E; Hagstrom, JN; Arruda, VR; Murphy, ML; Farrell, JP; High, KA; Herzog, RW
      Intravenous administration of an E1/E3-deleted adenoviral vector induces tolerance to factor IX in C57BL/6 mice

      GENE THERAPY
    6. High, KA
      Gene transfer as an approach to treating hemophilia

      CIRCULATION RESEARCH
    7. Hung, HL; Pollak, ES; Kudaravalli, RD; Arruda, V; Chu, K; High, KA
      Regulation of human coagulation factor X gene expression by GATA-4 and theSp family of transcription factors

      BLOOD
    8. Arruda, VR; Hagstrom, JN; Deitch, J; Heiman-Patterson, T; Camire, RM; Chu, K; Fields, PA; Herzog, RW; Couto, LB; Larson, PJ; High, KA
      Posttranslational modifications of recombinant myotube-synthesized human factor IX

      BLOOD
    9. Fields, PA; Kowalczyk, DW; Arruda, VR; Armstrong, E; McCleland, ML; Hagstrom, JN; Pasi, KJ; Ertl, HCJ; Herzog, RW; High, KA
      Role of vector in activation of T cell subsets in immune responses againstthe secreted transgene product factor IX

      MOLECULAR THERAPY
    10. Kay, MA; Manno, CS; Ragni, MV; Larson, PJ; Couto, LB; McClelland, A; Glader, B; Chew, AJ; Tai, SJ; Herzog, RW; Arruda, V; Johnson, F; Scallan, C; Skarsgard, E; Flake, AW; High, KA
      Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector

      NATURE GENETICS
    11. Herzog, RW; Arruda, VR; Fisher, TH; Read, MS; Nichols, TC; High, KA
      Absence of circulating factor IX antigen in hemophilia B dogs of the UNC-Chapel Hill colony

      THROMBOSIS AND HAEMOSTASIS
    12. High, KA
      Gene therapy in haematology and oncology

      LANCET
    13. Gollapalli, U; Dantus, MM; High, KA
      Environment and control issues in design

      COMPUTERS & CHEMICAL ENGINEERING
    14. Hagstrom, JN; Couto, LB; Scallan, C; Burton, M; McCleland, ML; Fields, PA; Arruda, VR; Herzog, RW; High, KA
      Improved muscle-derived expression of human coagulation factor IX from a skeletal actin/CMV hybrid enhancer/promoter

      BLOOD
    15. Camire, RM; Larson, PJ; Stafford, DW; High, KA
      Enhanced gamma-carboxylation of recombinant factor X using a chimeric construct containing the prothrombin propeptide

      BIOCHEMISTRY
    16. Herzog, RW; Yang, EY; Couto, LB; Hagstrom, JN; Elwell, D; Fields, PA; Burton, M; Bellinger, DA; Read, MS; Brinkhous, KM; Podsakoff, GM; Nichols, TC; Kurtzman, GJ; High, KA
      Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector

      NATURE MEDICINE
    17. Mendes, LJ; Tsai, TC; High, KA; High, MS; Tree, DA
      Model of processing-induced microstructure formation in polymeric materials

      JOURNAL OF POLYMER SCIENCE PART B-POLYMER PHYSICS
    18. Herzog, RW; High, KA
      Adeno-associated virus-mediated gene transfer of factor IX for treatment of hemophilia B by gene therapy

      THROMBOSIS AND HAEMOSTASIS
    19. Dantus, MM; High, KA
      Evaluation of waste minimization alternatives under uncertainty: a multiobjective optimization approach

      COMPUTERS & CHEMICAL ENGINEERING
    20. Stanley, TB; Humphries, J; High, KA; Stafford, DW
      Amino acids responsible for reduced affinities of vitamin K-dependent propeptides for the carboxylase

      BIOCHEMISTRY
    21. HERZOG RW; YANG EY; COUTO LB; HAGSTROM JN; ELWELL D; CHU K; KUNG SH; TAI SJ; MCQUISTON SA; COLOSI P; PODSAKOFF GM; READ MS; BELLINGER DA; BRINKHOUS KM; NICHOLS T; KURTZMAN GJ; HIGH KA
      AAV-MEDIATED GENE-TRANSFER IN DOGS WITH HEMOPHILIA-B

      Journal of investigative medicine
    22. Hagstrom, JN; Walter, J; Bluebond-Langner, R; Amatniek, JC; Manno, CS; High, KA
      Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease

      JOURNAL OF PEDIATRICS
    23. CAREW JA; POLLAK ES; HIGH KA; BAUER KA
      SEVERE FACTOR-VII DEFICIENCY DUE TO A MUTATION DISRUPTING AN SP1 BINDING-SITE IN THE FACTOR-VII PROMOTER

      Blood
    24. KUNG SH; HAGSTROM JN; CASS D; TAI SJ; LIN HF; STAFFORD DW; HIGH KA
      HUMAN FACTOR-IX CORRECTS THE BLEEDING DIATHESIS OF MICE WITH HEMOPHILIA-B

      Blood
    25. NAKAI H; HERZOG RW; HAGSTROM JN; WALTER J; KUNG SH; YANG EY; TAI SJ; IWAKI Y; KURTZMAN GJ; FISHER KJ; COLOSI P; COUTO LB; HIGH KA
      ADENOASSOCIATED VIRAL VECTOR-MEDIATED GENE-TRANSFER OF HUMAN BLOOD-COAGULATION FACTOR-IX INTO MOUSE-LIVER

      Blood
    26. LARSON PJ; CAMIRE RM; WONG D; FASANO NC; MONROE DM; TRACY PB; HIGH KA
      STRUCTURE FUNCTION ANALYSES OF RECOMBINANT VARIANTS OF HUMAN FACTOR XA - FACTOR XA INCORPORATION INTO PROTHROMBINASE ON THE THROMBIN-ACTIVATED PLATELET SURFACE IS NOT MIMICKED BY SYNTHETIC PHOSPHOLIPID-VESICLES/

      Biochemistry
    27. HIGH KA; BARTHET VJ; MCLAREN JW; BLAIS JS
      CHARACTERIZATION OF METALLOTHIONEIN-LIKE PROTEINS FROM ZEBRA MUSSELS (DREISSENA-POLYMORPHA)

      Environmental toxicology and chemistry
    28. HERZOG RW; HAGSTROM JN; KUNG SH; TAI SJ; WILSON JM; FISHER KJ; HIGH KA
      STABLE GENE-TRANSFER AND EXPRESSION OF HUMAN BLOOD-COAGULATION FACTOR-IX AFTER INTRAMUSCULAR INJECTION OF RECOMBINANT ADENOASSOCIATED VIRUS

      Proceedings of the National Academy of Sciences of the United Statesof America
    29. AMBROSINI G; PLESCIA J; CHU KC; HIGH KA; ALTIERI DC
      ACTIVATION-DEPENDENT EXPOSURE OF THE INTER-EGF SEQUENCE LEU(83)-LEU(88) IN FACTOR XA MEDIATES LIGAND-BINDING TO EFFECTOR CELL PROTEASE RECEPTOR-1

      The Journal of biological chemistry
    30. SWANSON CM; FASANO NC; WONG D; HIGH KA; LARSON PJ
      RESIDUE-103-106 OF HUMAN FACTOR XA ARE NOT INVOLVED IN THE TISSUE FACTOR PATHWAY INHIBITOR BINDING-SITE

      Blood
    31. SWANSON CM; HERZOG RW; KURTZMAN G; HIGH KA
      EFFECT OF ANTIRETROVIRAL DRUGS ON EFFICIENCY OF TRANSDUCTION AND EXPRESSION BY A RECOMBINANT AAV VECTOR EXPRESSING HUMAN FACTOR-IX

      Blood
    32. KUNG SH; HAGSTROM JN; CASS D; TAI S; LIN HF; HIGH KA
      ADENOVIRAL-MEDIATED EXPRESSION OF HUMAN FACTOR-IX CORRECTS THE BLEEDING DIATHESIS OF MICE WITH HEMOPHILIA-B

      Blood
    33. WU SM; STAFFORD DW; FRAZIER LD; FU YY; HIGH KA; CHU K; SANCHEZVEGA B; SOLERA J
      GENOMIC SEQUENCE AND TRANSCRIPTION START SITE FOR THE HUMAN GAMMA-GLUTAMYL CARBOXYLASE

      Blood
    34. ARBINI AA; POLLAK ES; BAYLERAN JK; HIGH KA; BAUER KA
      SEVERE FACTOR-VII DEFICIENCY DUE TO A MUTATION DISRUPTING A HEPATOCYTE NUCLEAR FACTOR-4 BINDING-SITE IN THE FACTOR-VII PROMOTER

      Blood
    35. POLLAK ES; HUNG HL; HIGH KA
      CRITICAL ELEMENTS IN THE HUMAN FACTOR-VII PROMOTER REGION

      The FASEB journal
    36. DANTUS MM; HIGH KA
      ECONOMIC-EVALUATION FOR THE RETROFIT OF CHEMICAL PROCESSES THROUGH WASTE MINIMIZATION AND PROCESS INTEGRATION

      Industrial & engineering chemistry research
    37. SRIDHARA S; CHAING S; HIGH KA; BLAJCHMAN MA; CLARKE BJ
      ACTIVATION OF A RECOMBINANT HUMAN FACTOR-VII STRUCTURAL ANALOG ALTERSITS AFFINITY OF BINDING TO TISSUE FACTOR

      American journal of hematology
    38. VANDERHELM DU; HIGH KA
      WASTE MINIMIZATION BY PROCESS MODIFICATION

      Environmental progress
    39. HAGSTROM JN; WALTER J; BLUEBONDLANGNER R; MANNO CS; HIGH KA
      PREVALENCE OF THE FACTOR-V LEIDEN MUTATION IN CHILDREN AND NEONATES WITH THROMBOEMBOLIC DISEASE

      Pediatric research
    40. WALTER J; YOU QM; HAGSTROM JN; SANDS M; HIGH KA
      SUCCESSFUL EXPRESSION OF HUMAN FACTOR-IX FOLLOWING REPEAT ADMINISTRATION OF AN ADENOVIRAL VECTOR IN MICE

      Proceedings of the National Academy of Sciences of the United Statesof America
    41. CHU K; WU SM; STANLEY T; STAFFORD DW; HIGH KA
      A MUTATION IN THE PROPEPTIDE OF FACTOR-IX LEADS TO WARFARIN SENSITIVITY BY A NOVEL MECHANISM

      The Journal of clinical investigation
    42. LARSON PJ; STANFIELDOAKLEY SA; VANDUSEN WJ; KASPER CK; SMITH KJ; MONROE DM; HIGH KA
      STRUCTURAL INTEGRITY OF THE GAMMA-CARBOXYGLUTAMIC ACID DOMAIN OF HUMAN BLOOD-COAGULATION FACTOR IXA IS REQUIRED FOR ITS BINDING TO COFACTORVIIIA

      The Journal of biological chemistry
    43. HUNG HL; HIGH KA
      LIVER-ENRICHED TRANSCRIPTION FACTOR HNF-4 AND UBIQUITOUS FACTOR NF-Y ARE CRITICAL FOR EXPRESSION OF BLOOD-COAGULATION FACTOR-X

      The Journal of biological chemistry
    44. POLLAK ES; HUNG HL; GODIN W; OVERTON GC; HIGH KA
      FUNCTIONAL-CHARACTERIZATION OF THE HUMAN FACTOR-VII 5'-FLANKING REGION

      The Journal of biological chemistry
    45. KUNG J; HAGSTROM N; WALTER J; FISHER K; HIGH KA
      IN-VIVO EXPRESSION OF THERAPEUTIC LEVELS OF HUMAN F.IX USING A RECOMBINANT ADENOASSOCIATED VIRAL (AAV) VECTOR

      Blood
    46. AMBROSINI G; PLESCIA J; CHU KC; HIGH KA; ALTIERI DC
      BINDING OF FACTOR XA TO EFFECTOR CELL PROTEASE RECEPTOR-1 (EPR-1) REQUIRES ACTIVATION-DEPENDENT RECOGNITION OF THE INTER-EGF SEQUENCE LEU(83)-LEU(88)

      Blood
    47. BLUEBONDLANGNER R; CHU K; HUNG HL; WU SM; HIGH KA
      CHARACTERIZATION OF THE HUMAN GAMMA-GLUTAMYL-CARBOXYLASE PROMOTER

      Blood
    48. LARSON PJ; WONG D; FASANO NC; MONROE DM; HIGH KA
      GLAS-16, GLAS-26, AND GLAS-29 ARE CRITICAL FOR NORMAL ACTIVITY OF HUMAN FACTOR XA

      Blood
    49. POLLAK ES; CAREW JA; ARBINI AA; HIGH KA; BAUER KA
      SEVERE FACTOR-VII DEFICIENCY DUE TO MUTATIONS DISRUPTING HNF-4 AND SP1 BINDING-SITES IN THE FACTOR-VII PROMOTER

      Blood
    50. BI L; LAWLER AM; ANTONARAKIS SE; HIGH KA; GEARHART JD; KAZAZIAN HH
      TARGETED DISRUPTION OF THE MOUSE FACTOR-VIII GENE PRODUCES A MODEL OFHEMOPHILIA-A

      Nature genetics
    51. HIGH KA; METHVEN BA; MCLAREN JW; SIU KWM; WANG J; KLAVERKAMP JF; BLAIS JS
      PHYSICOCHEMICAL CHARACTERIZATION OF METAL-BINDING PROTEINS USING HPLC-ICP-MS, HPLC-MA-AAS AND ELECTROSPRAY-MS

      Fresenius' journal of analytical chemistry
    52. WALTER J; YOU Q; MICKANIN C; BALDWIN HS; HIGH KA
      IN-UTERO INJECTION IN MICE OF ADENOVIRAL VECTORS EXPRESSING HUMAN FACTOR-IX RESULTS IN LOW-LEVEL GENE-TRANSFER AND DOES NOT INTERFERE WITH FETAL DEVELOPMENT

      Thrombosis and haemostasis
    53. POLLAK ES; HUNG HL; HIGH KA
      CHARACTERIZATION OF THE HUMAN FACTOR-VII PROMOTER

      Thrombosis and haemostasis
    54. HIGH KA; LAROCHE RD
      PARALLEL NONLINEAR OPTIMIZATION TECHNIQUES FOR CHEMICAL PROCESS DESIGN-PROBLEMS

      Computers & chemical engineering
    55. HIGH KA; BLAIS JS; METHVEN BAJ; MCLAREN JW
      PROBING THE CHARACTERISTICS OF METAL-BINDING PROTEINS USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY - ATOMIC-ABSORPTION SPECTROSCOPY AND INDUCTIVELY-COUPLED PLASMA-MASS SPECTROMETRY

      Analyst
    56. LOZIER JN; THOMPSON AR; HU PC; READ M; BRINKHOUS KM; HIGH KA; CURIEL DT
      EFFICIENT TRANSFECTION OF PRIMARY-CELLS IN A CANINE HEMOPHILIA-B MODEL USING ADENOVIRUS POLYLYSINE DNA COMPLEXES

      Human gene therapy
    57. CHIANG SH; WALLMARK A; BERNTORP E; HIGH KA
      A NLAIII POLYMORPHISM WITHIN THE HUMAN FACTOR-VII GENE

      Human genetics
    58. HIGH KA; KUBOW S
      N-3 FATTY-ACIDS INHIBIT DEFECTS AND FATTY-ACID CHANGES CAUSED BY PHENYTOIN IN EARLY GESTATION IN MICE

      Lipids
    59. HUNG HL; HIGH KA
      CHARACTERIZATION OF CIS AND TRANSREGULATORY ELEMENTS IN THE FACTOR-X PROMOTER

      Clinical research
    60. WALTER J; OHENEFREMPONG K; HIGH KA
      ANALYSIS OF THE FACTOR-V MUTATION ASSOCIATED WITH ACTIVATED PROTEIN-CRESISTANCE AND THROMBOEMBOLIC DISEASE IN SICKLE-CELL PATIENTS WITH STROKE

      Blood
    61. WALTER J; YOU Q; MICKANIN C; BALDWIN HS; HIGH KA
      IN-UTERO INJECTION IN MICE OF ADENOVIRAL VECTORS EXPRESSING HUMAN FACTOR-IX RESULTS IN LOW-LEVEL GENE-TRANSFER AND DOES NOT INTERFERE WITH FETAL DEVELOPMENT

      Blood
    62. CHAING S; CLARKE B; SRIDHARA S; CHU K; FRIEDMAN P; VANDUSEN W; ROBERTS HR; BLAJCHMAN M; MONROE DM; HIGH KA
      SEVERE FACTOR-VII DEFICIENCY CAUSED BY MUTATIONS ABOLISHING THE CLEAVAGE SITE FOR ACTIVATION AND ALTERING BINDING TO TISSUE FACTOR

      Blood
    63. SRIDHARA S; CLARKE BJ; HIGH KA; BLAJCHMAN MA
      THE EFFECT OF RECOMBINANT HUMAN FACTOR-VII STRUCTURAL ANALOGS ON THE BINDING OF BIOTINYLATED PLASMA FACTOR-VII TO RECOMBINANT HUMAN TISSUE FACTOR

      Thrombosis and haemostasis
    64. LARSON PJ; MONROE DM; HIGH KA
      THE ROLE OF INDIVIDUAL GAMMA-CARBOXYGLUTAMIC ACID RESIDUES IN THE FUNCTION OF HUMAN FACTOR-X

      Thrombosis and haemostasis
    65. WATZKE HH; LECHNER K; LARSON P; HIGH KA
      FACTOR-XVIENNA MOLECULAR ANALYSIS AND IN-VITRO EXPRESSION OF A SEVERECRM(-) FX DEFICIENCY

      Thrombosis and haemostasis
    66. HIGH KA; STANFIELDOAKLEY S; KASPAR C
      3 NOVEL MUTATIONS IN THE FACTOR-IX GENE RESULTING IN HEMOPHILIA-B

      Thrombosis and haemostasis
    67. HUNG HL; HIGH KA
      HEPATOCYTE NUCLEAR FACTOR-IV BINDS TO THE PROMOTERS OF FACTOR-VII, FACTOR-IX, AND FACTOR-X

      Thrombosis and haemostasis
    68. GIANNELLI F; GREEN PM; HIGH KA; SOMMER S; POON MC; LUDWIG M; SCHWAAB R; REITSMA PH; GOOSSENS M; YOSHIOKA A; BROWNLEE GG
      HEMOPHILIA-B - DATABASE OF POINT MUTATIONS AND SHORT ADDITIONS AND DELETIONS - 4TH EDITION, 1993

      Nucleic acids research
    69. SRIDHARA S; CLARKE BJ; OFOSU FA; HIGH KA; BLAJCHMAN MA
      THE DIRECT BINDING OF HUMAN FACTOR-VII IN PLASMA TO RECOMBINANT HUMANTISSUE FACTOR

      Thrombosis research
    70. LARSON PJ; STANFIELDOAKLEY S; KASPER CK; SMITH KJ; ROBERTS HR; MONROE DM; HIGH KA
      FIXLOS ANGELES 4 - A MUTATION IN THE GLA DOMAIN OF HUMAN FACTOR-IX RESULTS IN MARKEDLY DECREASED ACTIVITY OF FACTOR-IXA IN THE XASE COMPLEX

      Blood
    71. WALTER J; HUNG HL; HIGH KA
      CHARACTERIZATION OF THE HUMAN TFPI PROMOTER - NUCLEAR-PROTEIN BINDS AT POTENTIAL GATA SITES

      Blood
    72. KINGDON HS; BRAUKER JH; JOHNSON RC; CARRBRENDEL VE; LOZIER JN; HIGH KA
      AN IMMUNOISOLATION DEVICE WHICH FACILITATES CELL-BASED PROPHYLACTIC THERAPY FOR HEMOPHILIA

      Blood
    73. ROSE VL; DERMOTT SC; MURRAY BF; MCIVER MM; HIGH KA; OBERHARDT BJ
      DECENTRALIZED TESTING FOR PROTHROMBIN TIME AND ACTIVATED PARTIAL THROMBOPLASTIN TIME USING A DRY CHEMISTRY PORTABLE ANALYZER

      Archives of pathology and laboratory medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 11/08/20 alle ore 16:13:07